MRK: Merck & Co., Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 218,224.27
Enterprise Value ($M) 242,152.27
Book Value ($M) 44,560.00
Book Value / Share 17.64
Price / Book 4.90
NCAV ($M) -31,952.00
NCAV / Share -12.65
Price / NCAV -6.83

Profitability (mra)
Return on Invested Capital (ROIC) 0.21
Return on Assets (ROA) 0.16
Return on Equity (ROE) 0.45

Liquidity (mrq)
Quick Ratio 1.15
Current Ratio 1.36

Balance Sheet (mrq) ($M)
Current Assets 38,782.00
Assets 117,106.00
Liabilities 70,734.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 64,168.00
Operating Income 24,031.00
Net Income 17,117.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 21,468.00
Cash from Investing -7,734.00
Cash from Financing -7,032.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-06 13G/A Vanguard Group Inc 10.02 3.47

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-04 4,278,968 17,596,038 24.32
2025-04-03 1,910,764 10,032,316 19.05
2025-04-02 1,440,854 8,708,605 16.55
2025-04-01 1,799,608 11,010,674 16.34

(click for more detail)

Similar Companies
HYAC – Haymaker Acquisition Corp. 4 JNJ – Johnson & Johnson
LLY – Eli Lilly and Company NUVB – Nuvation Bio Inc.
OGN – Organon & Co.


Financial data and stock pages provided by
Fintel.io

Finpedia: Merck & Co